Læknablaðið

Ukioqatigiit

Læknablaðið - 15.12.1998, Qupperneq 12

Læknablaðið - 15.12.1998, Qupperneq 12
916 LÆKNABLAÐIÐ 1998; 84 Table I. Mortality figures-men. Number of men in each group in The Reykjavik Study and mortality figures used in the hazard ratio calculations. Mortality is shown as absolute numbers and as a percentage of each group. Total CHD Cancer Accidents All causes Men Number Mortality (%) Mortality (%) Mortality Mortality (%) Group 1 869 62 (7.1) 67 (7.7) 0 192 (22.1) Group 2 1115 123 (11.0) 107 (9.6) 2 326 (29.2) Group 3 4045 419 (10.4) 316 (7.8) 4 1058 (26.2) Group 4 3036 441 (14.5) 345 (11.4) 4 1171 (38.6) Ungrouped 74 8 (10.8) 5 (6.8) 0 17 (23.0) Total 9139 1053 (11.5) 840 (9.2) 10 2764 (30.2) Table II. Mortality figures- women. Number of women in each group in The Reykjavik Study and mortality figures used in the hazard ratio calculations. Mortality is shown as absolute numbers and as a percentage ofeach group. Total CHD Cancer Accidents All causes Women Number Mortality (%) Mortality (%) Mortality Mortality (%) Group 1 157 1 (0.6) 6 (3.8) 0 15 (9.6) Group 2 658 11 (1.7) 30 (4.6) 0 65 (9.9) Group 3 3648 83 (2.3) 211 (5.8) 5 442 (12.1) Group 4 5182 251 (4.8) 426 (8.2) 6 1096 (21.2) Ungrouped 128 3 (2.3) 3 (2.3) 0 7 (5.5) Total 9773 349 (3.6) 676 (6.9) 11 1625 (16.6) Table III. Coronary heart disease mortality. Hazard ratio (HR) in educational groups 1-3. Corrections are made for age and year of examination. Men Women HR 95% CI HR 95% CI Group 1 0.66 0.50-0.86 0.23 0.03-1.59 Group 2 0.85 0.69-1.04 0.53 0.29-0.96 Group 3 0.89 0.78-1.02 0.70 0.54-0.90 Group 1+2 0.77 0.65-0.92 0.47 0.26-0.84 95% CI: Confidence interval. P value for the relationship of education and coronary heart disease mortality: men: <0.02;women: <0.01. Table IV. Coronary heart disease mortality-corrections for risk factors. Hazard ratio (HR) in educational groups 1-3. Correc- tions are made for age, year of examination and riskfactors (to- tal cholesterol and triglycerides in serum, systolic blood pres- sure, sugar tolerance and smoking). Men Women HR 95% CI HR 95% CI Group 1 0.68 0.52-0.88 0.34 0.05-2.39 Group 2 0.86 0.70-1.05 0.63 0.34-1.15 Group 3 0.90 0.78-1.03 0.81 0.63-1.04 95% CI: Confidence interval. P value for the relationship of education and coronary heart disease mortality: men: < 0.03; women: >0.10. Table V. Trends in the relationship of educational status and mortality. Hazard ratio (HR)for each cause of deathfor men and women. P-valuefor each trend is shown, as well as 95% confidence interval (Cl). Corrections are madefor age and year of examination. Men Women HR P-value 95% CI____________________HR P-value 95% CI CHD 1.12 <0.002 1.05-1.21 1.43 <0.001 1.18-1.74 Cancer 1.06 >0.100 0.98-1.15 1.18 <0.010 1.04-1.33 All causes 1.11 <0.001 1.06-1.15_________1.24 <0.001 1.14-1.35 Table VI. Cancer mortality. Hazard ratio (HR) in educational groups 1-3. Corrections are made for age and year of examina- tion. Men Women HR 95% CI HR 95% CI Group 1 0.85 0.65-1.11 0.62 0.28-1.40 Group 2 0.92 0.74-1.14 0.70 0.48-1.02 Group 3 0.82 0.70-0.96 0.86 0.72-1.01 Group 1+2+3 0.84 0.73-0.97 0.83 0.70-0.97 95% CI: Confidence interval. P value for the relationship of education and cancer mortality: men: > 0.08; women: > 0.07. var marktæk bæði hjá konum og körlum (tafla V). Dauðsföll af völdum krabbameina: Það var minni hætta á dauðsfalli af völdum krabba- Table VII. Cancer mortality-corrections for risk factors. Hazard ratio (HR) in educational groups 1-3. Corrections are made for age, year of examination and risk factors (smoking). Men Women HR 95% CI HR 95% CI Group 1 0.89 0.68-1.16 0.69 0.31-1.55 Group 2 0.95 0.74-1.14 0.72 0.50-1.05 Group 3 0.83 0.71-0.97 0.91 0.77-1.07 95% CI: Confidence interval. P value for the relationship of education and cancer mortality: men: > 0.05; women: > 0.05. meina samfara meiri menntun, þar sem áhættu- hlutfallið var alls staðar lægra en 1,0 (tafla VI). Samband menntunar og dánartíðni var þó ekki marktækt, hvorki þegar leiðrétt var einungis
Qupperneq 1
Qupperneq 2
Qupperneq 3
Qupperneq 4
Qupperneq 5
Qupperneq 6
Qupperneq 7
Qupperneq 8
Qupperneq 9
Qupperneq 10
Qupperneq 11
Qupperneq 12
Qupperneq 13
Qupperneq 14
Qupperneq 15
Qupperneq 16
Qupperneq 17
Qupperneq 18
Qupperneq 19
Qupperneq 20
Qupperneq 21
Qupperneq 22
Qupperneq 23
Qupperneq 24
Qupperneq 25
Qupperneq 26
Qupperneq 27
Qupperneq 28
Qupperneq 29
Qupperneq 30
Qupperneq 31
Qupperneq 32
Qupperneq 33
Qupperneq 34
Qupperneq 35
Qupperneq 36
Qupperneq 37
Qupperneq 38
Qupperneq 39
Qupperneq 40
Qupperneq 41
Qupperneq 42
Qupperneq 43
Qupperneq 44
Qupperneq 45
Qupperneq 46
Qupperneq 47
Qupperneq 48
Qupperneq 49
Qupperneq 50
Qupperneq 51
Qupperneq 52
Qupperneq 53
Qupperneq 54
Qupperneq 55
Qupperneq 56
Qupperneq 57
Qupperneq 58
Qupperneq 59
Qupperneq 60
Qupperneq 61
Qupperneq 62
Qupperneq 63
Qupperneq 64
Qupperneq 65
Qupperneq 66
Qupperneq 67
Qupperneq 68
Qupperneq 69
Qupperneq 70
Qupperneq 71
Qupperneq 72
Qupperneq 73
Qupperneq 74
Qupperneq 75
Qupperneq 76
Qupperneq 77
Qupperneq 78
Qupperneq 79
Qupperneq 80
Qupperneq 81
Qupperneq 82
Qupperneq 83
Qupperneq 84
Qupperneq 85
Qupperneq 86
Qupperneq 87
Qupperneq 88
Qupperneq 89
Qupperneq 90
Qupperneq 91
Qupperneq 92
Qupperneq 93
Qupperneq 94
Qupperneq 95
Qupperneq 96
Qupperneq 97
Qupperneq 98
Qupperneq 99
Qupperneq 100
Qupperneq 101
Qupperneq 102
Qupperneq 103
Qupperneq 104
Qupperneq 105
Qupperneq 106
Qupperneq 107
Qupperneq 108
Qupperneq 109
Qupperneq 110
Qupperneq 111
Qupperneq 112
Qupperneq 113
Qupperneq 114
Qupperneq 115
Qupperneq 116
Qupperneq 117
Qupperneq 118
Qupperneq 119
Qupperneq 120

x

Læknablaðið

Direct Links

Hvis du vil linke til denne avis/magasin, skal du bruge disse links:

Link til denne avis/magasin: Læknablaðið
https://timarit.is/publication/986

Link til dette eksemplar:

Link til denne side:

Link til denne artikel:

Venligst ikke link direkte til billeder eller PDfs på Timarit.is, da sådanne webadresser kan ændres uden advarsel. Brug venligst de angivne webadresser for at linke til sitet.